Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
暂无分享,去创建一个
Gudrun Schleiermacher | Isabelle Janoueix-Lerosey | Olivier Delattre | Delphine Lequin | Thierry Frebourg | Virginie Raynal | O. Delattre | T. Frebourg | A. Puisieux | S. Lyonnet | V. Combaret | I. Janoueix-Lerosey | L. Brugières | J. Amiel | G. Schleiermacher | L. Pontual | G. Pierron | J. Michon | V. Raynal | D. Valteau‐Couanet | Valérie Combaret | Gaëlle Pierron | Laurence Brugières | Agnès Ribeiro | Loïc de Pontual | Alain Puisieux | Dominique Valteau-Couanet | Jean Michon | Stanislas Lyonnet | Jeanne Amiel | A. Ribeiro | D. Lequin | D. Valteau-Couanet
[1] R. Sakai,et al. Activation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell lines , 2002, Oncogene.
[2] G. Brodeur. Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.
[3] 筬島 裕子,et al. Biological role of anaplastic lymphoma kinase in neuroblastoma , 2006 .
[4] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[5] Anne Vincent-Salomon,et al. ESR1 gene amplification in breast cancer: a common phenomenon? , 2008, Nature Genetics.
[6] J. Trent,et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc , 1984, Nature.
[7] J. Griffin,et al. The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.
[8] A. Iafrate,et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. , 2008, Cancer research.
[9] Isabelle Janoueix-Lerosey,et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. , 2005, Cancer letters.
[10] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[11] Rongshi Li,et al. Development of anaplastic lymphoma kinase (ALK) small‐molecule inhibitors for cancer therapy , 2008, Medicinal research reviews.
[12] K. Pulford,et al. Expression of the ALK tyrosine kinase gene in neuroblastoma. , 2000, The American journal of pathology.
[13] Laura A. Sullivan,et al. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.
[14] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[15] Peter G. Schultz,et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK , 2007, Proceedings of the National Academy of Sciences.
[16] Stevan R. Hubbard,et al. Juxtamembrane autoinhibition in receptor tyrosine kinases , 2004, Nature Reviews Molecular Cell Biology.
[17] A. R.,et al. Review of literature , 1951, American Potato Journal.
[18] G. Inghirami,et al. The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination , 2008, Nature Medicine.
[19] L. Shun. An Orally Available Small-Molecule Inhibitor of c-Met,PF-2341066,Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms , 2010 .
[20] Roberto Piva,et al. The anaplastic lymphoma kinase in the pathogenesis of cancer , 2008, Nature Reviews Cancer.
[21] O. Delattre,et al. Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes , 2008, Genes, chromosomes & cancer.
[22] Stefan Fröhling,et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. , 2007, Cancer cell.
[23] C. Preudhomme,et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature , 2008, Leukemia.
[24] Familial neuroblastoma: a complex heritable disease. , 2003, Cancer letters.
[25] G. Inghirami,et al. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. , 2003, Blood.
[26] H. Satoh,et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Griffin,et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. , 1999, Cancer research.